Norway -
Norwegian -
Statens legemiddelverk
alvesco 80 mikrog/ dose
covis pharma europe b.v. - ciklesonid - inhalasjonsaerosol, oppløsning - 80 mikrog/ dose
Norway -
Norwegian -
Statens legemiddelverk
alvesco 160 mikrog/ dose
covis pharma europe b.v. - ciklesonid - inhalasjonsaerosol, oppløsning - 160 mikrog/ dose
European Union -
Norwegian -
EMA (European Medicines Agency)
tezspire
astrazeneca ab - tezepelumab - astma - legemidler for obstruktive sykdommer i luftveiene, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.